Abstract
Cushing’s syndrome is associated with high cardiovascular morbility and mortality. Blood pressure (BP) variability within a 24-h period is increasingly recognized as an independent predictor of cardiovascular risk. The aim of our study was to investigate the short-term BP variability indices in Cushing’s syndrome. Twenty-five patients with Cushing’s syndrome (mean age 49 ± 13 years, 4 males; 21 Cushing’s disease and 4 adrenal adenoma patients) underwent 24-h ambulatory BP monitoring (ABPM) and evaluation of cardiovascular risk factors. Cushing patients were divided into 8 normotensive (NOR-CUSH) and 17 hypertensive (HYP-CUSH) patients and were compared with 20 normotensive (NOR-CTR) and 20 hypertensive (HYP-CTR) age-, sex-, and BMI-matched control subjects. Short-term BP variability was derived from ABPM and calculated as the following: (1) standard deviation (SD) of 24-h, daytime, and nighttime BP; (2) 24-h weighted SD of BP; and (3) average real variability (ARV), i.e., the average of the absolute differences between consecutive BP measurements over 24 h. In comparison with controls, patients with Cushing’s syndrome, either normotensive or hypertensive, had higher 24-h and daytime SD of BP, as well as higher 24-h weighted SD and ARV of BP (P = 0.03 to P < 0.0001). No difference in metabolic parameters was observed between NOR-CTR and NOR-CUSH or between HYP-CTR and HYP-CUSH subgroups. ABPM-derived short-term BP variability is increased in Cushing’s syndrome, independent of BP elevation. It may represent an additional cardiovascular risk factor in this disease. The role of excess cortisol in BP variability has to be further clarified.
Similar content being viewed by others
References
M. Boscaro, L. Barzon, F. Fallo, N. Sonino, Cushing’s syndrome. Lancet 357, 783–791 (2001)
L. Tauchmanovà, R. Rossi, B. Biondi, M. Pulcrano, V. Nuzzo, E.A. Palmieri, S. Fazio, G. Lombardi, Patients with subclinical Cushing’s syndrome due to adrenal adenoma have increased cardiovascular risk. J. Clin. Endocrinol. Metab. 87, 4872–4878 (2002)
G. Arnaldi, A. Angeli, A. Atkinson, X. Bertagna, F. Cavagnini, G.P. Chrousos, G.A. Fava, J.W. Findling, R.C. Gaillard, A.B. Grossman, B. Kola, A. Lacroix, T. Mancini, F. Mantero, J. Newell-Price, L.K. Nieman, N. Sonino, M.L. Vance, A. Giustina, M. Boscaro, Diagnosis and complications of Cushing’s syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 88, 5593–5602 (2003)
R. Giordano, F. Guaraldi, R. Berardelli, I. Karamouzis, V. D’Angelo, E. Marinazzo, A. Picu, E. Ghigo, E. Arvat, Glucose metabolism in patients with subclinical Cushing’s syndrome. Endocrine 41, 415–423 (2012)
J.A. Withworth, G.J. Mangos, J.J. Kelly, Cushing, cortisol, and cardiovascular disease. Hypertension 36, 912–916 (2000)
B.R. Walker, Glucocorticoids and cardiovascular disease. Eur. J. Endocrinol. 157, 545–559 (2007)
F. Fallo, N. Sonino, Should we evaluate for cardiovascular disease in patients with Cushing’s syndrome? Clin. Endocrinol. (Oxf.) 71, 768–771 (2009)
F. Fallo, G. Famoso, D. Capizzi, N. Sonino, F. Dassie, P. Maffei, C. Martini, A. Paoletta, S. Iliceto, F. Tona, Coronary microvascular function in patients with Cushing’s syndrome. Endocrine 43, 206–213 (2013)
M.A. Magiakou, P. Smyrnaki, G.P. Chrousos, Hypertension in Cushing’s syndrome. Best Pract. Res. Clin. Endocrinol. Metab. 20, 467–482 (2006)
M.V. Cicala, F. Mantero, Hypertension in Cushing’s syndrome: from pathogenesis to treatment. Neuroendocrinology 92(Suppl 1), 44–49 (2010)
Y. Imai, K. Abe, S. Sasaki, N. Minami, M. Nihei, M. Munakata, O. Murakami, K. Matsue, H. Sekino, Y. Miura, Altered circadian blood pressure rhythm in patients with Cushing’s syndrome. Hypertension 12, 11–19 (1988)
Y. Imai, A. Aihara, T. Ohkubo, K. Nagai, I. Tsuji, N. Minami, H. Satoh, S. Hisamichi, Factors that affect blood pressure variability. A community-based study in Ohasama, Japan. Am. J. Hypertens. 10, 1281–1289 (1997)
C. Cuspidi, G. Macca, L. Sampieri, V. Fusi, B. Severgnini, I. Michev, M. Salerno, F. Magrini, A. Zanchetti, Target organ damage and non-dipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed essential hypertensive patients. J. Hypertens. 19, 1539–1545 (2001)
T. Ohkubo, A. Hozawa, J. Yamaguchi, M. Kikuya, K. Ohmori, M. Michimata, M. Matsubara, J. Hashimoto, H. Hoshi, T. Araki, I. Tsuji, H. Satoh, S. Hisamichi, Y. Imai, Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J. Hypertens. 20, 2183–2189 (2002)
M. Kikuya, A. Hozawa, T. Ohokubo, I. Tsuji, M. Michimata, M. Matsubara, M. Ota, K. Nagai, T. Araki, H. Satoh, S. Ito, S. Hisamichi, Y. Imai, Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 36, 901–906 (2000)
L. Mena, S. Pintos, N.V. Queipo, J.A. Aizpúrua, G. Maestre, T. Sulbarán, A reliable index for the prognostic significance of blood pressure variability. J. Hypertens. 23, 505–511 (2005)
G. Bilo, A. Giglio, K. Styczkiewicz, G. Caldara, A. Maronati, K. Kawecka-Jaszcz, G. Mancia, G. Parati, A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall. J. Hypertens. 25, 2058–2066 (2007)
S.D. Pierdomenico, M. Di Nicola, A.L. Esposito, R. Di Mascio, E. Ballone, D. Lapenna, F. Cuccurullo, Prognostic value of different indices of blood pressure variability in hypertensive patients. Am. J. Hypertens. 22, 842–847 (2009)
JCS Joint Working Group, Guidelines for the clinical use of 24 h ambulatory blood pressure monitoring (ABPM) (JCS 2010): digest version. Circ. J. 76, 508–519 (2012)
G. Mancia, Short- and long-term blood pressure variability. Present and future. Hypertension 60, 512–517 (2012)
G. Parati, J.E. Ochoa, P. Salvi, C. Lombardi, G. Bilo, Prognostic value of blood pressure variability and average blood pressure levels in patients with hypertension and diabetes. Diabetes Care 36(Suppl 2), S312–S324 (2013)
G. Mancia, R. Fagard, K. Narkiewicz, J. Redón, A. Zanchetti, M. Böhm, T. Christiaens, R. Cifkova, G. De Backer, A. Dominiczak, M. Galderisi, D.E. Grobbee, T. Jaarsma, P. Kirchhof, S.E. Kjeldsen, S. Laurent, A.J. Manolis, P.M. Nilsson, L.M. Ruilope, R.E. Schmieder, P.A. Sirnes, P. Sleight, M. Viigimaa, B. Waeber, F. Zannad, ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 31, 1281–1357 (2013)
P. Della Mea, M. Lupia, V. Bandolin, S. Guzzon, N. Sonino, R. Vettor, F. Fallo, Adiponectin, insulin resistance, and left ventricular structure in dipper and nondipper essential hypertensive patients. Am. J. Hypertens. 18, 30–35 (2005)
S.C. Malpas, Neural influences on cardiovascular variability: possibilities and pitfalls. Am. J. Physiol. Heart Circ. Physiol. 282, H6–H20 (2002)
T.N. Thrasher, Baroreceptors and the long-term control of blood pressure. Exp. Physiol. 89, 331–335 (2004)
J.A. Whitworth, M.A. Brown, J.J. Kelly, P.M. Williamson, Mechanisms of cortisol-induced hypertension in humans. Steroids 60, 76–80 (1995)
J.A. Whitworth, P.M. Williamson, G. Mangos, J.J. Kelly, Cardiovascular consequences of cortisol excess. Vasc. Health Risk Manag. 1, 291–299 (2005)
F. Fallo, P. Maffei, A. Dalla Pozza, M. Carli, P. Della Mea, M. Lupia, F. Rabbia, N. Sonino, Cardiovascular autonomic function in Cushing’s syndrome. J. Endocrinol. Invest. 32, 41–45 (2009)
D.S. Chandran, N. Ali, A.K. Jaryal, V.P. Jyotsna, K.K. Deepak, Decreased autonomic modulation of heart rate and altered cardiac sympathovagal balance in patients with Cushing’s syndrome: role of endogenous hypercortisolism. Neuroendocrinology 97, 309–317 (2013)
A. Faggiano, R. Pivonello, S. Spiezia, M.C. De Martino, M. Filippella, C. Di Somma, G. Lombardi, A. Colao, Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing’s disease during active disease and 1 year after disease remission. J. Clin. Endocrinol. Metab. 88, 2527–2533 (2003)
N. Albiger, R.M. Testa, B. Almoto, M. Ferrari, F. Bilora, F. Petrobelli, A. Pagnan, F. Mantero, C. Scaroni, Patients with Cushing’s syndrome have increased intimal media thickness at different vascular levels: comparison with a population matched for similar cardiovascular risk factors. Horm. Metab. Res. 38, 405–410 (2006)
M. Baykan, C. Erem, O. Gedikli, A. Hacihasanoglu, T. Erdogan, M. Kocak, I. Durmuş, L. Korkmaz, S. Celik, Impairment of flow-mediated vasodilatation of brachial artery in patients with Cushing’s syndrome. Endocrine 31, 300–304 (2007)
G. Schillaci, G. Bilo, G. Pucci, S. Laurent, I. Macquin-Mavier, P. Boutouyrie, F. Battista, L. Settimi, G. Desamericq, G. Dolbeau, A. Faini, P. Salvi, E. Mannarino, G. Parati, Relationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension 60, 369–377 (2012)
R. van der Pas, F.W. Leebeek, L.J. Hofland, W.W. de Herder, R.A. Feelders, Hypercoagulability in Cushing’s syndrome: prevalence, pathogenesis and treatment. Clin. Endocrinol. (Oxf.) 78, 481–488 (2013)
M. Ozawa, K. Tamura, Y. Okano, K. Matsushita, M. Yanagi, Y. Tsurumi-Ikeya, J. Oshikawa, T. Hashimoto, S. Masuda, H. Wakui, A. Shigenaga, K. Azuma, T. Ishigami, Y. Toya, T. Ishikawa, S. Umemura, Identification of an increased short-term blood pressure variability on ambulatory blood pressure monitoring as a coronary risk factor in diabetic hypertensives. Clin. Experim. Hypertens. 31, 259–270 (2009)
N. Sonino, F. Fallo, G.A. Fava, Psychosomatic aspects of Cushing’s syndrome. Rev. Endocr. Metab. Disord. 11, 95–104 (2010)
G. van den Berg, M. Frölich, J.D. Veldhuis, F. Roelfsema, Combined amplification of the pulsatile and basal modes of adrenocorticotropin and cortisol secretion in patients with Cushing’s disease: evidence for decreased responsiveness of the adrenal glands. J. Clin. Endocrinol. Metab. 80, 3750–3757 (1995)
R.G. Veldman, M. Frölich, S.M. Pincus, J.D. Veldhuis, F. Roelfsema, Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing’s disease after clinically successful transsphenoidal adenomectomy. J. Clin. Endocrinol. Metab. 85, 4039–4046 (2000)
L. Kornel, W.A. Nelson, B. Manisundaram, R. Chigurupati, T. Hayashi, Mechanism of the effects of glucocorticoids and mineralocorticoids on vascular smooth muscle contractility. Steroids 58, 580–587 (1993)
H. Inoue, K. Umesono, T. Nishimori, Y. Hirata, T. Tanabe, Glucocorticoid-mediated suppression of the promoter activity of the cyclooxygenase-2 gene is modulated by expression of its receptor in vascular endothelial cells. Biochem. Biophys. Res. Commun. 254, 292–298 (1999)
S.L. Ong, J.A. Whitworth, How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress, and eicosanoids. Endocrinol. Metab. Clin. N. Am. 40, 393–407 (2011)
J.E. Goodwin, D.S. Geller, Glucocorticoid-induced hypertension. Pediatr. Nephrol. 27, 1059–1066 (2012)
Conflict of interest
The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported. This research did not receive any specific grant from any funding agency in the public commercial or non-profit section.
Author information
Authors and Affiliations
Corresponding author
Additional information
Andrea Rebellato and Andrea Grillo have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Rebellato, A., Grillo, A., Dassie, F. et al. Ambulatory blood pressure monitoring-derived short-term blood pressure variability is increased in Cushing’s syndrome. Endocrine 47, 557–563 (2014). https://doi.org/10.1007/s12020-014-0164-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-014-0164-7